HomeABVC • NASDAQ
add
ABVC Biopharma Inc
Previous close
$2.67
Day range
$2.67 - $2.87
Year range
$0.40 - $5.48
Market cap
65.86M USD
Avg Volume
62.72K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 795.95K | 104.47% |
Operating expense | 1.96M | 180.94% |
Net income | -1.25M | -215.76% |
Net profit margin | -156.61 | -54.43% |
Earnings per share | — | — |
EBITDA | -1.16M | -283.68% |
Effective tax rate | -0.04% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 257.24K | 23.58% |
Total assets | 21.18M | 46.42% |
Total liabilities | 6.68M | 3.09% |
Total equity | 14.49M | — |
Shares outstanding | 22.84M | — |
Price to book | 5.34 | — |
Return on assets | -15.58% | — |
Return on capital | -20.37% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -1.25M | -215.76% |
Cash from operations | -133.26K | -321.25% |
Cash from investing | -1.27M | -2,940.73% |
Cash from financing | 1.13M | 1,491.90% |
Net change in cash | -222.42K | -920.60% |
Free cash flow | -1.35M | -227.65% |
About
Founded
2015
Website
Employees
18
